Promoter 2 -1025 T/C polymorphism in the RUNX2 gene is associated with femoral neck BMD in Spanish postmenopausal women

Calcified Tissue International

Volumn 81, Issue 4, 2007, Pages 327-332

  Bustamante, Mariona ^a,b   Nogués, Xavier ^c   Águeda, Lídia ^a,b   Jurado, Susana ^c   Wesselius, Anke ^a   Cáceres, Enrique ^c   Carreras, Ramon ^c   Ciria, Manel ^c   Mellibovsky, Leonardo ^c   Balcells, Susana ^a,b   Díez Pérez, Adolfo ^c   Grinberg, Daniel ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Association; BMD; CBFA1; Osteoporosis; RUNX2

Indexed keywords

GENE PRODUCT; TRANSCRIPTION FACTOR RUNX2;

AGE DISTRIBUTION; ANALYSIS OF COVARIANCE; ARTICLE; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; COHORT ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FEMUR NECK; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSSIFICATION; OSTEOPOROSIS; PHENOTYPE; POSTMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION;

ABSORPTIOMETRY, PHOTON; AGED; ALLELES; BONE DENSITY; CORE BINDING FACTOR ALPHA 1 SUBUNIT; FEMALE; FEMUR NECK; GENE FREQUENCY; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS; POLYMORPHISM, GENETIC; POSTMENOPAUSE; PROMOTER REGIONS (GENETICS); SPAIN;

EID: 34848816852     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-007-9069-2     Document Type: Article

References (21)

1. Ducy P, Karsenty G (1995) Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 15:1858-1869
2. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747-754
3. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764
4. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771
5. Liu WG, Toyosawa S, Furuichi T, Kanatani N, Yoshida C, Liu Y, Himeno M, Narai S, Yamaguchi A, Komori T (2001) Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol 155:157-166
6. Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsenty G (1999) A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 13:1025-1036
7. Kawahata H, Kikkawa T, Higashibata Y, Sakuma T, Huening M, Sato M, Sugimoto M, Kuriyama K, Terai K, Kitamura Y, Nomura S (2003) Enhanced expression of Runx2/PEBP2alphaA/CBFA1/AML3 during fracture healing. J Orthop Sci 8:102-108
8. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JH, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR (1997) Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89:773-779
9. Otto F, Kanegane H, Mundlos S (2002) Mutations in the RUNX2 gene in patients with clelidocranial dysplasia. Hum Mutat 19:209-216
10. Geoffroy V, Corral DA, Zhou L, Lee B, Karsenty G (1998) Genomic organization, expression of the human CBFA1 gene, and evidence for an alternative splicing event affecting protein function. Mamm Genome 9:54-57
11. Xiao Z, Thomas R, Hinson TK, Quarles LD (1998) Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor. Gene 214:187-197
12. Terry A, Kilbey A, Vaillant F, Stewart M, Jenkins A, Cameron E, Neil JC (2004) Conservation and expression of an alternative 3′ exon of Runx2 encoding a novel proline-rich C-terminal domain. Gene 336:115-125
13. Stock M, Otto F (2005) Control of RUNX2 isoform expression: the role of promoters and enhancers. J Cell Biochem 95:506-517
14. Xiao Z, Hjelmeland AB, Quarles LD (2004) Selective deficiency of the "bone-related" Runx2-II unexpectedly preserves osteoblast-mediated skeletogenesis. J Biol Chem 279:20307-20313
15. Vaughan T, Pasco JA, Kotowicz MA, Nicholson GC, Morrison NA (2002) Alleles of RUNX2/CBFA1 gene are associated with differences in bone mineral density and risk of fracture. J Bone Miner Res 17:1527-1534
16. Vaughan T, Reid DM, Morrison NA, Ralston SH (2004) RUNX2 alleles associated with BMD in Scottish women; interaction of RUNX2 alleles with menopausal status and body mass index. Bone 34:1029-1036
17. Doecke JD, Day CJ, Stephens AS, Carter SL, van Daal A, Kotowicz MA, Nicholson GC, Morrison NA (2006) Association of functionally different RUNX2 P2 promoter alleles with BMD. J Bone Miner Res 21:265-273
18. Napierala D, Garcia-Rojas X, Sam K, Wakui K, Chen C, Mendoza-Londono R, Zhou G, Zheng Q, Lee B (2005) Mutations and promoter SNPs in RUNX2, a transcriptional regulator of bone formation. Mol Genet Metab 86:257-268
19. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265
20. Purcell S, Cherny SS, Sham PC (2003) Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149-150
21. Riggs BL, Parfitt AM (2005) Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling. J Bone Miner Res 20:177-184